Radar · Industry landscape · India
Life Sciences Industry Landscape of India
2,471 Life Sciences companies in India, in one picture: who is hiring, who is raising money, who founded them, where they are based, what the news is about, which skills employers want and where the research is going. Updated September 2026.
2,471companies tracked
$3Bdisclosed funding
290hiring right now
531events · 24 months
42,125news articles · 12 months
Who leads Life Sciences in India
Tracks 2,471 Indian life‑sciences firms, highlighting which are hiring, which have recent funding rounds, and the top companies in hiring and financing.
open roles
Hiring now
ranked by live open roles
- 01
Thermo Fisher Scientific13last posted Aug 2026
- 02
Cochlear9last posted Aug 2026
- 03
Medtronic8last posted Aug 2026
- 04
ConvaTec7last posted Mar 2026
- 05
Sova Health6last posted Aug 2026
- 06
Kapiva6last posted Aug 2026
- 07
HaystackAnalytics6last posted Jul 2026
- 08
UltraCare PRO5last posted Aug 2026
290 companies hiring · 75 posted in the last 30 days
disclosed funding
Most funded
disclosed totals, all rounds
- 01
- 02
MedGenome$264.7MSeries E · Jul 2025
- 03
Molbio Diagnostics$124MGrant (prize money) · Jan 2023
- 04
Ascent Health & Wellness Solutions$91.7MSeries C · Mar 2023
- 05
- 06
Fullife$78.1MSeries D · Mar 2026
- 07
Accumax$68MSeries C · May 2022
- 08
Redcliffe Genetics$63.2MSeries B · May 2022
398 companies with disclosed rounds · $3B total
revenue
Revenue leaders
official filings first, else latest snapshot
- 01
Serum Institute of India$1.2BFY2022 filing
- 02
Herbalife$1.1BFY2021 filing
- 03
Dr.Morepen$186.5MFY2024 filing
- 04
Indian Immunologicals$175.1MFY2024 filing
- 05
Bharat Biotech$174.5MFY2022 filing
- 06
- 07
SMT$122.5Msnapshot Mar 2025
- 08
Nuziveedu Seeds$112.9MFY2025 filing
248 companies with a revenue figure
headcount
Largest teams
ranked by tracked headcount
- 01
- 02
- 03
DentCare3,782tracked employees
- 04
- 05
LifeCell1,188tracked employees
- 06
- 07
- 08
168 companies with headcount data
share of events
Share of voice
share of all tracked sector news events, 24 months
- 01
- 02
Axio5.1%44 tracked events
- 03
- 04
4baseCare3.5%30 tracked events
- 05
SS Innovations International3.3%28 tracked events
- 06
- 07
- 08
Protein Design2.7%23 tracked events
857 tracked events across 106 companies
articles
In the news
Prism news coverage, last 12 months
- 01
- 02
- 03
- 04
- 05
OZiva106articles in the window
- 06
Setu98articles in the window
- 07
Wellbeing Nutrition92articles in the window
- 08
Shunya88articles in the window
98 of these companies drew sector coverage in the window
Radar
See all 2,471 Life Sciences companies in India
Filter by funding, headcount, hiring and location, and export the list.
How the Life Sciences ecosystem in India grew, 2016–2025
Shows the number of companies founded each year, with a peak of 191 new firms in 2020 and 50 in 2025.
Companies founded / year
new Life Sciences companies in India
20162025
peak 191 in 2020
Companies raising / year
with a disclosed round that year
20162025
peak 107 in 2021
Disclosed funding / year
sum of disclosed rounds (USD)
20162025
peak $707.9M in 2020
Where Life Sciences companies in India are based
Hub 01
Bengaluru
403 Life Sciences companies
25% of the Life Sciences companies across these hubs
403companies
$1Bdisclosed funding
56hiring now
Hub 02
Delhi
242 Life Sciences companies
15% of the Life Sciences companies across these hubs
242companies
$27.5Mdisclosed funding
22hiring now
Hub 03
Mumbai
236 Life Sciences companies
15% of the Life Sciences companies across these hubs
236companies
$938.8Mdisclosed funding
29hiring now
Hub 04
Hyderabad
235 Life Sciences companies
15% of the Life Sciences companies across these hubs
235companies
$177.5Mdisclosed funding
36hiring now
Hub 05
Chennai
138 Life Sciences companies
9% of the Life Sciences companies across these hubs
138companies
$140.1Mdisclosed funding
19hiring now
Hub 06
Pune
133 Life Sciences companies
8% of the Life Sciences companies across these hubs
133companies
$59.4Mdisclosed funding
16hiring now
Hub 07
Ahmedabad
126 Life Sciences companies
8% of the Life Sciences companies across these hubs
126companies
$26.1Mdisclosed funding
22hiring now
Hub 08
Gurugram
83 Life Sciences companies
5% of the Life Sciences companies across these hubs
83companies
$59.8Mdisclosed funding
17hiring now
The Life Sciences market map of India: what these companies actually do
Breaks down product sub‑categories and revenue models, noting the largest groups such as enterprise tech (1,629 firms) and the most common sales approaches like e‑commerce product sales (1,360).
- Enterprise Tech1,629 companies · $2B raised · 207 hiring
- Medical Devices660 companies · $966.3M raised · 102 hiring
- Consumer Digital635 companies · $1.1B raised · 74 hiring
- Healthtech479 companies · $455.9M raised · 59 hiring
- Nutritional Formula380 companies · $321.9M raised · 40 hiring
- Enterprise Software340 companies · $439.6M raised · 42 hiring
- Deep Tech305 companies · $802.9M raised · 47 hiring
- Biopharmaceuticals180 companies · $357.5M raised · 18 hiring
- SaaS179 companies · $208.1M raised · 23 hiring
- Healthtech SaaS144 companies · $134.9M raised · 16 hiring
- In Vitro Diagnostics139 companies · $223.3M raised · 14 hiring
- Food as Medicine117 companies · $77.2M raised · 14 hiring
Monetization
How Life Sciences companies make money
How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
E-Commerce - Product1,360
Physical Commerce1,086
Subscription541
Fee-For-Service388
Commission on Transaction84
Advertising70
E-Commerce - Service57
Sponsorship8
Funding, M&A and the deals moving Life Sciences in India
Counts 531 corporate events in the past two years, including 158 funding rounds, 103 mergers and acquisitions, and 81 earnings releases.
Funding 158M&A 103Earnings 81Leadership 53Contracts 26Capital 24Assets 18IPO 16Announcement 13Regulatory 10
- M&AParexel has acquired pharmaceutical operations software vendor Vitrana.2026-05-01
- M&AThermo Fisher Scientific said it has signed a definitive agreement to sell its microbiology business to Astorg, a pan-European private equity firm, for consideration of approximately $1.075 billion.2026-04-27
- M&AHindustan Unilever’s acquisition of the residual 49% stake in plant-based nutrition brand OZiva, valuing the D2C brand at about ₹1,682 crore.2026-04-20
- M&ANykaa has already acquired brands like Nudge Wellness and Dot & Key skincare to enhance its portfolio in the beauty retail space.2026-04-06
- Funding"Fullife Healthcare raised $31.62 million."2026-03-30
- M&AUSV Private Ltd acquired around a 79% stake in nutraceutical firm Wellbeing Nutrition in an all-cash deal valuing the company at ₹1,583 crore in February.2026-03-25
- M&AThe acquisition has been executed via a Business Transfer Agreement (BTA), marking Eris Lifesciences’ strategic expansion into the growing probiotics and microbiome-based therapeutics segment.2026-03-23
- FundingRobotic neuro-rehabilitation startup, Rymo Technologies, raised over ₹10 crore in a seed round led by IAN Angel Fund.2026-03-19
- M&AKedaara Capital, the homegrown private equity firm ... is preparing to sell Universal NutriScience (UNS).2026-03-10
- FundingSS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII ), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that on March 6, 2026, the Company completed a private placement of its common stock (the “Private Placement”) which generated approximately $18.6 million in gross proceeds, before deducting offering expenses.2026-03-09
Mergers and acquisitions
Deals from the last 24 months where a Life Sciences company in India was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
| Acquirer | Target | Deal value | Status | Date |
|---|---|---|---|---|
| undisclosed | Announced | 2026-05-01 | ||
| $1.1B | Announced | 2026-04-27 | ||
| undisclosed | Announced | 2026-04-21 | ||
| undisclosed | Announced | 2026-04-21 | ||
| undisclosed | Completed | 2026-04-17 | ||
| undisclosed | Announced | 2026-04-07 |
Who is listing, hiring leaders, launching and winning work
Details notable corporate actions such as IPO filings, leadership changes, product launches, and contract wins.
IPO pipeline
12 companies listed or filing · last 24 months
Hexagon NutritionIPO · BSE (NSE) · 2 reportsFeb 2026
Genetix BiotechIPO · 1 reportSep 2025
RJ BiotechIPO · 1 reportJan 2025
KMSIPO · 1 reportJan 2025
Leadership moves
11 tracked people moves · last 12 months
Botanic HealthcareKamalakar V Arcot · Appointment → Group Chief Executive OfficerApr 2026
Utkal TubersVinod Bhat · Appointment → Chief Executive OfficerMar 2026
NutrifyTodayMTI Khasim · Promotion → Executive Director of Research & Development and CommercializationJan 2026
Contract wins
16 customer wins · last 24 months
CuraTeQ Biologicswon stada arzneimittel agMar 2026
Voxelgridswon Sathya Sai InstituteMar 2026
Elicowon cerecoOct 2025
Regulatory & litigation
12 regulatory events · 2 tracked suits · 24 months
- thermo fisher scientific v income tax departmentdepreciation on goodwill and business/commercial rights under Income Tax Act 1961 · SettledAug 2025
- genentech v Protein Designpatent coverage of Xolair · OngoingFeb 2025
Earnings pulse
companies reporting results · last 24 months
18 companies reporting87 company-quarters trackedbeat 23miss 6in line 0
Half of these companies grew revenue faster than +6.0%, half slower.
Who is building Life Sciences in India
Profiles 2,221 founders and CEOs across 1,595 firms, noting frequent alma maters like IIT Bombay (28) and prior employers such as Microsoft (6).
Founders and chief executives12 of 2,221, from the best-funded companies on this page
Founder Emerge Ventures, Co-Founder GenomeAsia 100K. IIT Madras B.Tech 1993, IIM Calcutta MBA 1995
repeat founder
Co-Founder-PharmEasy, API Holdings · Ex-Co-Founder-DIAL HEALTH CARE INDIA · IIM Ahmedabad MBA 2012
repeat founder
CEO Capp Aps, Neuation Technologies, Fine Care Biosystems. L M College of Pharmacy BPharm 1989
repeat founder
Ex-Barclays, American Express, J.P. Morgan. IIT Varanasi BTech 2009, SGH Warsaw School of Economics 2011, Management Development Institute…
Ex-Shasun · Anna University Chennai BTech 2000, Northwestern University MSc 2001
Ex-Tribune, American Express, Ago Synthesis · IIT Kharagpur BTech 2000, PhD 2006
Co-Founder & CEO-Pandorum MSU Baroda MSC 2005, IISc PhD 2012
Ex-Cellworks Research India, Magma Design Automation India, Monterey Design Systems, Cadence Design Systems. Anna University Chennai BE 1986…
Goapptiv, ex-Health Care Industry, ex-Pfizer, Indian Institute of Technology, Bombay, 2018
Where the founders studied
alma mater on record for 282 of 2,221 founders
IIT Bombay28
BITS Pilani27
IIT Delhi22
IIT Kharagpur20
Indian School of Business19
IIT Madras15
IIT Kanpur13
IIT Roorkee13
Where they worked before
a previous employer on record for 24 of 2,221 founders
Microsoft6
McKinsey4
Amazon3
Flipkart3
Myntra2
Boston Consulting Group2
Goldman Sachs2
Zoho1
Founders flagged as repeat founders
of 2,002 founders with a profile on this page
24
carry a repeat-founder flag
- flagged as repeat founders24
- no repeat-founder flag1,978
Radar
Look up the people behind Life Sciences companies in India
Search founders, executives and operators by company, role and location.
Who funds Life Sciences in India
Records 1,148 funding rounds since 2016 from 3,217 investors, with a typical round size of $300 k.
| Investor · most active investors since 2016 | Rounds | Led | Latest |
|---|---|---|---|
| Startup Karnataka | 42 | — | Jan 2023 |
| Indian Angel Network | 34 | 20 | Mar 2026 |
| C-CAMP | 34 | 13 | Nov 2025 |
| BIRAC | 29 | 2 | Mar 2025 |
| SINE | 25 | 16 | Dec 2024 |
| Social Alpha | 18 | 8 | Oct 2025 |
| Raman Roy | 17 | 1 | Sep 2024 |
| Fireside Ventures | 15 | 9 | Nov 2025 |
| Accel | 14 | 7 | Jan 2023 |
| Chiratae Ventures | 14 | 3 | Jan 2023 |
Stage mix · rounds since 2016
Seed & Angel753
Series A–B151
Series C+ / PE25
Grants, debt & other219
The typical round is $300k — half were bigger, half smaller.
The biggest Life Sciences funding rounds in India
Highlights the largest disclosed round—Molbio Diagnostics' $85 M Series C—and lists ten other major recent rounds.
| Company | Round | Size | When | Backers |
|---|---|---|---|---|
| Series C | $85M | Sep 2022 | Temasek, Motilal Oswal Financial Services | |
| Series C | $68M | May 2022 | Moringa, Gandaraditya Chola, Creador +1 more | |
| Series B | $61M | May 2022 | LeapFrog Investments, HealthQuad, Schroders +4 more | |
| Series D | $55M | Apr 2020 | LeapFrog Investments, Sofina, Peak XV Partners | |
| Series D | $50M | Aug 2022 | Novo Holdings, Sofina, LeapFrog | |
| Series E | $47.5M | Jul 2025 | Maj Invest, Novo Holdings, Sofina | |
| Series C | $40M | Mar 2018 | HDFC, HDFC Life, HDFC Mutual Fund +2 more | |
| Series B | $36.2M | Mar 2024 | Anil Manibhai Naik, Vipul Chandra, RNG Family Private Trust +23 more | |
| Series D | $32M | Mar 2026 | Elev8, Orchid Asia Group | |
| Series B | $30.5M | Sep 2021 | Orbimed |
Venture round sizes · 2023–2025
<$1M150
$1–10M78
$10–50M19
$50–250M0
>$250M0
247 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
Series A$2MMay 2026
Seed$1.9MMay 2026
Seed$650kMay 2026
Seed$1.1MMar 2026
Seed$760kMar 2026
Series B$429kMar 2026
How this industry appears in the news
Indexes 42,125 news articles from the last year, with most coverage on vaccine development, drug pricing, and generic drug trends.
News volume
Life Sciences coverage across India · articles per quarter
2021Q22026Q1
peak 18,615 in 2021Q2 · 42,125 articles in the last 12 tracked months
Tone of coverage
share of articles by dominant sentiment (positive / neutral / negative)
202120232025
Positive-tone share moved 68% → 77%, negative 30% → 21% across 2021–2025.
Most-covered companies · last 12 months
- 1,524
- 1,343
- 269
- 109
- 106
- 98
- 92
- 88
- 84
- 71
98 Life Sciences companies here were named in the news over this period.
Prism
Watch Life Sciences coverage in India as it happens
Prism follows these subjects story by story — which companies are named, what is said about them and how the tone moves.
Life Sciences jobs in India: who is hiring and what they ask for
Aggregates 2,150 job postings from 155 firms, showing top skills like Python and SQL and a median advertised salary of $9 k per year.
2,150postings · last 12 months
2,657postings tracked overall
155employers advertising
$9kmedian advertised salary/yr (n=149)
Demand
The Skills Employers Ask For
What Life Sciences employers in India put in their job ads. The bar is how many postings ask for it; the arrow shows whether demand grew or shrank against the year before.
- python304▲
- sql285▲
- project management224▲
- aws156▲
- java143▲
- sales121▲
- excel113▲
- git112▲
- communication112▲
- data analysis106▲
What level are these roles?
Entry44
Intern52
Senior457
Lead184
Manager656
What they pay, by level
- Manager$9k/yr (n=34)
Most advertised titles
- 32
- 32
- 32
- 29
- 23
- 21
What Life Sciences research in India is working on
Summarizes 2,919 India‑affiliated academic papers, classifying 1,802 as identifying opportunities, 388 as noting common problems, and 86 as issuing cautions.
How this field talks about itself
India-affiliated Life Sciences papers (gold) against all published research (grey)
Promising49.0% · 37.5%1.3×
Descriptive19.3% · 17.6%≈ par
Breakthrough12.8% · 26.1%0.5×
Problem-identifying12.6% · 9.8%1.3×
Cautionary2.9% · 4.2%0.7×
Comparative2.7% · 3.9%0.7×
India-affiliated Life Sciences literature runs 1.3× more “promising” than science at large (49.0% vs 37.5% baseline).
How the work is done
Empirical45.1%
Reviews40.9%
Methods-led10.4%
Position pieces3.2%
Theoretical0.4%
How the research reads
93% positive · 3% neutral · 4% negative, across 2,919 papers.
The institutions doing the work · India
- 7k
- 6k
- 6k
- 5k
- 5k
- 5k
ranked by how often their work is cited
Leading researchers · India-affiliated work
Archana Panche · A D Diwan · Sheela Chandra · Kanti Bhooshan Pandey · Syed Ibrahim Rizvi · J. E. Till · E. A. McCulloch · Rajeev K. Varshney
The most-cited breakthroughs
- Biomedical photoacoustic imaging · 2k cites
- Engineering circular RNA for potent and stable translation in eukaryotic cells · 794 cites
- Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infe · 734 cites
- Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity · 614 cites
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation · 595 cites
Common problems researchers identify363 papers · 7 recurring themes
Problems · theme 01
Food Safety and Security
65 papers · 17.9% of this block
▼ -24% share2022→2025 share of research on this subject
Researchers highlight risks in food safety, processing, and population nutrition, emphasizing need for sustainable management.
Food safety · Population · Food processing · Food security
“Aflatoxins: A Global Concern for Food Safety, Human Health and Their Management”
65 of these papers raise it as a problem
Problems · theme 02
Medicinal Plant Challenges
61 papers · 16.8% of this block
▲ +14% share2022→2025 share of research on this subject
Papers discuss difficulties in replicating phytochemical extraction and drug development from medicinal plants.
Medicinal plants · Drug · Phytochemical · Replication
“Significance of Antioxidant Potential of Plants and its Relevance to Therapeutic Applications”
61 of these papers raise it as a problem
Problems · theme 03
Biomass and Biofuel Barriers
58 papers · 16.0% of this block
▲ +8% share2022→2025 share of research on this subject
Studies point to technical hurdles in bioprocessing, synthetic biology, and sustainable biofuel production.
Biomass · Bioprocess · Biofuel · Synthetic biology
“Antimicrobial active packaging with biopolymers and natural extracts: sustainable solutions and technological challenges”
58 of these papers raise it as a problem
Problems · theme 04
Crop Genetics and Traits
55 papers · 15.2% of this block
▲ +22% share2022→2025 share of research on this subject
Authors note constraints in germplasm improvement, trait stability, and disease impact on yields.
Crop · Agriculture · Germplasm · Trait
“Disease Impact on Wheat Yield Potential and Prospects of Genetic Control”
55 of these papers raise it as a problem
Problems · theme 05
Antibiotic Resistance Concerns
49 papers · 13.5% of this block
▲ +10% share2022→2025 share of research on this subject
Research flags rising antimicrobial resistance and the need for new defensive strategies.
Antibiotic resistance · Antibiotics · Antimicrobial · Resistance
“Antimicrobial Resistance”
49 of these papers raise it as a problem
Problems · theme 06
Sustainable Agriculture Issues
42 papers · 11.6% of this block
▲ +30% share2022→2025 share of research on this subject
Works identify challenges in applying nanotechnology and other methods for long‑term food security.
Agriculture · Food security · Sustainability · Sustainable agriculture
“Nanotechnology in Sustainable Agriculture: Recent Developments, Challenges, and Perspectives”
42 of these papers raise it as a problem
Problems · theme 07
Abiotic Stress in Plants
33 papers · 9.1% of this block
▼ -23% share2022→2025 share of research on this subject
Papers examine how abiotic factors and rhizosphere interactions affect plant resilience.
Abiotic stress · Abiotic component · Rhizosphere · Gut flora
“Salicylic acid-induced abiotic stress tolerance and underlying mechanisms in plants”
33 of these papers raise it as a problem
Cautions80 papers · 4 recurring themes
Cautions · theme 01
Caution on Antimicrobial Strategies
29 papers · 36.2% of this block
▲ +25% share2022→2025 share of research on this subject
Authors urge careful evaluation of new antimicrobial and antifungal approaches before widespread use.
Antimicrobial · Antibiotic resistance · Resistance · Antifungal
“Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods”
29 of these papers raise it as a problem
Cautions · theme 02
Nutraceutical Health Risks
26 papers · 32.5% of this block
▲ +56% share2022→2025 share of research on this subject
Studies caution about uncertain health benefits and shelf‑life issues of nutraceuticals.
Nutraceutical · Human health · Health benefits · Shelf life
“Advances in Edible Coatings for Fresh Fruits and Vegetables: A Review”
26 of these papers raise it as a problem
Cautions · theme 03
Genotoxicity and Oxidative Stress
20 papers · 25.0% of this block
▼ -21% share2022→2025 share of research on this subject
Research warns of DNA damage and oxidative stress linked to certain interventions.
DNA damage · Trait · Oxidative stress · Genotype
“Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies”
20 of these papers raise it as a problem
Cautions · theme 04
Methodological Uncertainties
5 papers · 6.2% of this block
Papers highlight gaps in analytical methods and stress response interpretations.
“Analytical Methods for Identification and Quantification of Quinoa Saponins: A Review”
5 of these papers raise it as a problem
Opportunities1,738 papers · 7 recurring themes
Opportunities · theme 01
Gene Regulation for Cancer Therapy
372 papers · 21.4% of this block
▼ -31% share2022→2025 share of research on this subject
Investigations explore how modulating gene expression can trigger apoptosis and cytotoxic effects.
Downregulation and upregulation · Apoptosis · Gene · Cytotoxicity
“Apoptotic and Anti-Proliferative Potential of Spirulina platensis Methanolic Extract Against the Human Breast Cancer Cell Line MDA-MB-231: A”
Opportunities · theme 02
Microbial Biopesticides
254 papers · 14.6% of this block
▲ +24% share2022→2025 share of research on this subject
Research shows promise in using microbes and their metabolites to control plant diseases.
Antimicrobial · Fungicide · Antibiotic resistance · Biological pest control
“Harnessing secondary metabolites of endophytic microbes: a next-generation biopesticide for crop disease management”
Opportunities · theme 03
Fermented Feed Enhancements
252 papers · 14.5% of this block
→ -0% share2022→2025 share of research on this subject
Studies reveal benefits of fermented feed ingredients for animal growth and nutrient utilization.
Feed conversion ratio · Broiler · Nutrient · Fermentation
“Effect of Dietary Supplementation of Mushroom (Agaricus bisporus) Fruiting Body Waste Powder on Growth Performance, Nutrient Utilization and”
Opportunities · theme 04
Genomics‑Driven Crop Resilience
232 papers · 13.3% of this block
▲ +21% share2022→2025 share of research on this subject
Works focus on integrating genomics and breeding to improve drought tolerance and food security.
Agriculture · Crop · Abiotic stress · Food security
“Integrated genomics, physiology and breeding approaches for improving drought tolerance in crops”
Opportunities · theme 05
Sustainable Biomass Utilization
223 papers · 12.8% of this block
▲ +90% share2022→2025 share of research on this subject
Papers discuss green synthesis and valorization of agri‑food by‑products for biofuel and biotech.
Sustainability · Production · Biomass · Biofuel
“Advances in green synthesis of nanoparticles for biomedical applications: Antimicrobial, antiviral, and cancer therapies”
Opportunities · theme 06
Genetic Diversity for Yield
222 papers · 12.8% of this block
▼ -8% share2022→2025 share of research on this subject
Research emphasizes leveraging germplasm variability to boost crop productivity.
Heritability · Germplasm · Genetic diversity · Yield
“Assessment of Genetic Variability for Yield-Related Traits in Lentil (Lens culinaris Medik.) Germplasms”
Opportunities · theme 07
Phytochemicals for Health
183 papers · 10.5% of this block
▲ +28% share2022→2025 share of research on this subject
Studies highlight medicinal plants and nutraceuticals as sources of health‑promoting compounds.
Phytochemical · Medicinal plants · Nutraceutical · Health benefits
“Phytochemistry, pharmacology, and traditional uses of beverage plants with dietary hormetic potential for human health”
Which of these themes are growing fastest
Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Sustainable Agriculture Issues▲+30%
Crop Genetics and Traits▲+22%
Medicinal Plant Challenges▲+14%
Antibiotic Resistance Concerns▲+10%
Biomass and Biofuel Barriers▲+8%
Abiotic Stress in Plants▼-23%
Food Safety and Security▼-24%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Nutraceutical Health Risks▲+56%
Caution on Antimicrobial Strategies▲+25%
Genotoxicity and Oxidative Stress▼-21%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Sustainable Biomass Utilization▲+90%
Phytochemicals for Health▲+28%
Microbial Biopesticides▲+24%
Genomics‑Driven Crop Resilience▲+21%
Fermented Feed Enhancements▼-0%
Genetic Diversity for Yield▼-8%
Gene Regulation for Cancer Therapy▼-31%
Prism
Go deeper on Life Sciences research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
Keep going
Track Life Sciences in India beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs, news and research trackers, covering India. Counts are of companies we track, not of every company that exists. Updated September 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.
Where demand signals run ahead of mapped supply — India
Every demand signal in India’s newsflow, measured as a share of the country’s own coverage (2025-05-01 to 2026-05-01, against the year before), then scored beside family-matched supply — the companies in each signal’s mapped life sciences categories — as within-page percentiles. The gap is signal percentile minus supply percentile — a prioritisation clue in percentile points, not a market size.
The opportunity, in one view
signal family
signal pctile
supply pctile
gap · bar scaled to ±50 pts
gap pts
vs prior yr
Air pollutionenvironmental driver
signal pctile50
supply pctile10
gap pts+40
vs prior yr-0%
Infectious outbreaksdisease burden
signal pctile35.7
supply pctile10
gap pts+25.7
vs prior yr+4.8%
Layoffs & income shocksspending pressure
signal pctile57.1
supply pctile40
gap pts+17.1
vs prior yr▲ +77%
Maternal & child healthdisease burden
signal pctile64.3
supply pctile80
gap pts-15.7
vs prior yr▲ +58.6%
Cancer burdendisease burden
signal pctile28.6
supply pctile60
gap pts-31.4
vs prior yr▲ +50.5%
Diabetes, hypertension & cardiac burdendisease burden
signal pctile50
supply pctile100
gap pts-50
vs prior yr▲ +94.6%
Mental healthdisease burden
signal pctile64.3
supply pctile—
this page’s market map carries no matching category
gap pts—
vs prior yr▲ +54.5%
Ageing & elder caredisease burden
signal pctile50
supply pctile—
this page’s market map carries no matching category
gap pts—
vs prior yr▲ +82.4%
Where the signals are loudest
Each region’s reading is a share of its own coverage, so a loud smaller region can outrank a large one; rows follow each story’s primary region tag.
region
signal /10k articles · bar scaled to top row
top families
Delhi
top familiesAir pollution, Mental health, Layoffs & income shocks
Haryana
top familiesMental health, Air pollution, Maternal & child health
Madhya Pradesh
top familiesMental health, Maternal & child health, Infectious outbreaks
Chandigarh
top familiesMental health, Air pollution, Diabetes, hypertension & cardiac burden
Kerala
top familiesMental health, Infectious outbreaks, Maternal & child health
Uttar Pradesh
top familiesMental health, Air pollution, Maternal & child health
Karnataka
top familiesMental health, Infectious outbreaks, Layoffs & income shocks
Rajasthan
top familiesMental health, Maternal & child health, Infectious outbreaks
Odisha
top familiesMental health, Infectious outbreaks, Maternal & child health
Telangana
top familiesMental health, Maternal & child health, Cancer burden
showing the ten highest-signal regions of 12 readings.
Inside the three leading signals
+40 percentile-point gap
Air pollution
the operating hypothesis
Sustained air-quality stress can pull respiratory and cardiac care demand with it.
36.86 /10k articles, 12-month share -0% vs prior yr
quarterly share /10k
2024Q32026Q1
where it concentrates · /10k of that region’s coverage
Delhi235.7
Haryana68.2
Chandigarh43.7
+25.7 percentile-point gap
Infectious outbreaks
the operating hypothesis
Outbreak pressure can pull testing, surveillance and rapid-care demand at short notice.
11.96 /10k articles, 12-month share +4.8% vs prior yr
quarterly share /10k
2024Q32026Q1
where it concentrates · /10k of that region’s coverage
Madhya Pradesh50.2
Kerala47.9
Odisha29.1
+17.1 percentile-point gap
Layoffs & income shocks
the operating hypothesis
Layoff cycles can pull discretionary spend back toward value offerings.
11.25 /10k articles, 12-month share ▲ +77% vs prior yr
quarterly share /10k
2024Q32026Q1
where it concentrates · /10k of that region’s coverage
Karnataka21.4
Maharashtra11.3
For who is hiring, raising and leading here, see this page’s leader boards and market map above.
Related research & where the coverage is heading
The research below carries both a life sciences term and this page’s geography in its title — context for the boards above, not proof of any single number. The keywords are the fastest-growing terms in India coverage of this page's demand families, measured as a share of that coverage year-over-year so volume drift cancels.
Related research · life sciences in India
“Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health”
“Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1”
“COVID-19 Awareness Among Healthcare Students and Professionals in Mumbai Metropolitan Region: A Questionnaire-Based Survey”
“Multidrug-Resistant <i>Candida auris</i> Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020”
What’s growing in this coverage
frailty hypertension
60 articles, last 12mo
exercise fatigue oncology
56 articles, last 12mo
hypertensive cardiomegaly
61 articles, last 12mo
geriatric deaths
48 articles, last 12mo
crib death
57 articles, last 12mo
negligence fatalities
49 articles, last 12mo
Prism
Take these signals further
Everything on this board comes from the same data Prism serves live — the coverage, the companies named in it, and how the tone moves.
Explore Prism
The research and news intelligence layer behind this page — follow any of these signals story by story, in reports that refresh as the coverage moves.
Open PrismFor your team
A custom dashboard for your company
Your categories, your competitors and the demand signals that move your market — in one live view that updates as the coverage does, built for your team on the same data behind this page.
Request a dashboardEvery company behind these supply counts is tracked on Radar — hiring, funding, filings and headcount, live and searchable.